Abstract: Disclosed herein are compounds of formula I: or a pharmaceutically acceptable salt thereof, where the variables are as defined herein. These compounds are useful in treating RET associated cancers. Formulations containing the compounds of formula I and methods of making the compounds of formula I are also disclosed.

Abstract: Provided herein are RET kinase inhibitors according to the formula: pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods for their use in the treatment of diseases that can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders. A, R1, n, X1, X2, X3, X4, and R2 have the meanings given in the specification.

Abstract: An apparatus for total intravenous anesthesia includes at least one supply and infusion pump for an intravenous anesthesia agent carried by the apparatus housing, and at least one monitor for monitoring the characteristics of the patient during the total intravenous anesthesia. The at least one intravenous anesthesia agent preferably includes a first intravenous anesthesia agent, and more preferably, an analgesic, having a relatively quick offset so that the effects wears off relatively quickly upon stopping intravenous infusion. For monitoring the patient, the apparatus preferably includes at least one of an electrocardiogram, a blood oxygen monitor, a blood carbon dioxide monitor, inspiration/expiration oxygen, inspiration/expiration carbon dioxide, a blood pressure monitor, a pulse rate monitor, a respiration rate monitor, and a patient temperature monitor, for example. The first intravenous anesthesia agent may be an esterase metabolized opioid, such as remifentanil.

Abstract: An apparatus is described for moving a probe (12) that engages moving living tissue such as a heart or an artery that is penetrated by the probe, which moves the probe in synchronism with the tissue to maintain the probe at a constant location with respect to the tissue. The apparatus includes a servo positioner (18) which moves a servo member (20) to maintain a constant distance from a sensed object (30) while applying very little force to the sensed object, and a follower (26) having a stirrup (28) at one end resting on a surface of the living tissue and another end carrying a sensed object (30) adjacent to the servo member. A probe holder (34) has one end mounted on the servo member (20) and another end which holds the probe (12). The probe is held adjacent to the stirrup (28) of the follower assembly, so that movements of the tissue and therefore of the follower assembly (26) result in corresponding movement of the probe (12) to follow the surface of the tissue.